Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrapapillary Botulinum Toxin Injection for PREvention of Post-surgical PAncREactic Fistula

NCT04220931 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04220931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrapapillary Botulinum Toxin Injection for PREvention of Post-surgical PAncREactic Fistula
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Not applicable
Overall status
Recruiting
Start date
March 27, 2023
Completion date
March 1, 2027
Enrollment
460 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

distal pancreatectomy, postoperative pancreatic fistula